You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
Biomedical Advanced Research and Development Authority (BARDA)
BARDA Strategic Plan 2011 - 2016
BARDA’s Anthrax Medical Countermeasure Strategy and Portfolio
BARDA's Medical Countermeasure Response to Zika
CARB-X
Studies on the Burden, Trajectory, and Forecast for Sepsis
BARDA Strategic Plan 2011-2016
ASPR Blog Series: Combatting Antibiotic Resistance
BARDA TechWatch Meetings
Biography: Gary L. Disbrow, Ph.D.
Chief Operating Officer
ASPR Internships
ASPR Newsroom
Office of Financial Planning and Analysis (OFPA)
FY 2013 Budget in Brief
Public Health and Social Services Emergency Fund
Public Health and Social Services Emergency Fund FY 2015 Operating Plan
Office of Policy and Planning (OPP)
Division of Healthcare System Policy
Division of International Health Security
DURC Workshop
MCSR
Division of Biosafety, Biosecurity, and Countering Biological Threats
On the Front Line of Biodefense
Division of Policy and Strategic Planning
Office of Emergency Management (OEM)
Division of Recovery
The PREP Division
Recent
AMCG
BARDA Broad Agency Announcement
Contracts
Grants Management
Other Transactions for Advanced Research
About AMCG
ASPR Careers
Benefits, Leave and Compensation
Working At ASPR
The Hiring Process
About ASPR
ASPR Year in Review
A year of strengthening response
Alternative description for a year of strengthening response infographic
A year of advancing readiness
Alternative text for readiness infographic
A year of medical innovation
A year of cultivating connections
Alternative text for innovation infographic
Program Offices & Leadership
ASPR Program Offices
Strategic National Stockpile
Federal Medical Stations
About the Strategic National Stockpile
Stockpile Responses
Stockpile Products
Sustaining the Stockpile
SNS Training and Exercises
Stockpile Stakeholders: Global Responders
The Stockpile Stands Ready to Deliver
Inventory Management and Tracking System (IMATS)
Strategic National Stockpile Course Listing
Preparing Minnesota to Receive, Stage, and Store Stockpile Products in a Public Health Emergency
SNS 2.0: The Next Generation
Site Contents
Skip over global navigation links
Office of the Assistant Secretary for Preparedness and Response
Preparedness
Emergency
About ASPR
Public Health Emergency - Leading a Nation Prepared
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Right Box1 Content
Right Box2 Content
ASPR Mission and Key Priorities
Mission Areas
Providing Strong Leadership
Building a Regional Disaster Health Response System
Sustaining Robust and Reliable Public Health Security Capabilities
Advancing an Innovative Medical Countermeasures Enterprise
In Focus
ASPR Blog
ASPR Newsroom
ASPR Strategic Plan
ASPR Year in Review
Media Inquiries
Learn More
ASPR Highlights
Medical Countermeasures
BARDA Medical Countermeasures Programs
Public Health Emergency Medical Countermeasures Enterprise
Centers for Innovation in Advanced Development and Manufacturing
Strategic National Stockpile
Strategic Direction
National Health Security Strategy
National Biodefense Strategy
Public Health and Medical
Regional Disaster Health Response System
Hospital Preparedness Program
Critical Infrastructure Protection
Service and Volunteering
National Disaster Medical System
Medical Reserve Corps
Learn More
Technical Assistance and Tools
Technical Assistance
ASPR Technical Resources, Assistance Center, and Information Exchange (TRACIE)
Regional Emergency Coordinators
GIS-Based Tools
HHS emPOWER Map
GeoHEALTH
Social Media Analysis
NowTrending.HHS.gov
Threat-Specific Tools
CHEMM: Chemical Hazards Emergency Medical Management
REMM: Radiation Emergency Medical Management
WISER: Wireless Information System for Emergency Responders
Public Service Announcements
Public Service Announcements for Disasters
Learn More
Budget and Funding
Funding
Public Health and Social Services Emergency Fund: Operating Plan for FY 2019
2019 Public Health and Social Services Emergency Fund: Justification of Estimates for Appropriations Committee
Budget
ASPR FY2021 Budget in Brief
Public Health Emergency Medical Countermeasures Enterprise Multiyear Budget FY 2019-2022
Learn More
Doing Business with ASPR
Medical Countermeasure Acquisitions
BARDA Tech Watch Meetings
Core Services
BARDA DRIVe EZ BAA
CARB-X: Combatting Antibiotic Resistant Bacteria
BARDA Broad Agency Announcement
Search for Open Business Opportunities
SAM.gov
Grants.gov
Novel Coronvirus Partnership Opportunities
COVID-19 MCM Market Research Initiative
EZ-BAA for Molecular Diagnostics & Nonclinical Assays
BARDA BAA: Pan-Coronavirus Diagnostics AOI
ASPR Contracting and Grants
Contracting
Other Transaction Agreements
Grants Management
Learn More
Careers at ASPR
Applying for Positions
Hiring Process
Joining NDMS
Internships at ASPR
Applying to the USPHS Commissioned Corps
Working at ASPR
Schedule and Workplace Flexibility
Career Development
Location
Benefits, Leave and Compensation
Healthcare Benefits
Life Insurance
Salary
Leave and Holdays
Wellness
Learn More
Program Offices and Leadership
Offices
Office of the Principal Deputy Assistant Secretary
Biomedical Advanced Research and Development Authority
Office of Incident Command and Control
Organization and Leadership
Robert Kadlec, M.D., MTM&H, M.S.
David Christian Hassell, Ph.D.
Organization Chart
Learn More
Connect with ASPR
In the News
Newsroom
Blog
ASPR Public Affairs Staff Contacts
Connect with ASPR
Email
Twitter
Facebook
Flickr
YouTube
LinkedIn
Learn More
In the Spotlight
About Spotlight
News & Events
News
December 15, 2020: HHS, DOD engage Quantum Leap Research Collaborative in search for effective treatments for the sickest COVID-19 patients
December 11, 2020: Trump Administration purchases additional 100 million doses of COVID-19 investigational vaccine from Moderna
December 2, 2020: Trump Administration purchases additional doses of Lilly therapeutic to treat patients with mild to moderate COVID-19
November 23, 2020: HHS Allocates Regeneron Therapeutic to Treat Patients With Mild to Moderate COVID-19
October 30, 2020: Trump Administration Producing Supply Kits to Safely Administer COVID-19 Vaccines to Americans
Archives
Most Popular
About Most Popular
ASPR's COVID-19 Response
ASPR Response Overview
Medical Countermeasures available Under Emergency Use Authorization or Licensed
Casirivimab/
Imdevimab
Bamlanivimab
Medical Countermeasures under Development
Partnering with BARDA on COVID-19 MCMs
Strategic National Stockpile
Watch, Listen, Subscribe
Site Map
Link to
site map
Can't find what you want?
This page last reviewed: December 17, 2020
